164 related articles for article (PubMed ID: 10348713)
1. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study.
Lindahl TL; Lundahl TH; Nilsson L; Andersson CA
Thromb Haemost; 1999 Jan; 81(1):18-21. PubMed ID: 10348713
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
5. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
[TBL] [Abstract][Full Text] [Related]
8. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
9. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
10. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
[TBL] [Abstract][Full Text] [Related]
12. Frequency and timing of clinical venous thromboembolism after major joint surgery.
Bjørnarå BT; Gudmundsen TE; Dahl OE
J Bone Joint Surg Br; 2006 Mar; 88(3):386-91. PubMed ID: 16498018
[TBL] [Abstract][Full Text] [Related]
13. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
14. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
15. A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty.
Joseph JE; Low J; Courtenay B; Neil MJ; McGrath M; Ma D
Br J Haematol; 2005 Apr; 129(1):87-92. PubMed ID: 15801960
[TBL] [Abstract][Full Text] [Related]
16. Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.
Cohn DM; Hermanides J; DeVries JH; Kamphuisen PW; Kuhls S; Homering M; Hoekstra JB; Lensing AW; Büller HR
Thromb Haemost; 2012 Feb; 107(2):225-31. PubMed ID: 22187097
[TBL] [Abstract][Full Text] [Related]
17. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
[TBL] [Abstract][Full Text] [Related]
18. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.
Pellegrini VD; Donaldson CT; Farber DC; Lehman EB; Evarts CM
Clin Orthop Relat Res; 2006 Nov; 452():21-7. PubMed ID: 16906107
[TBL] [Abstract][Full Text] [Related]
19. [Influence of body mass index and age on deep vein thrombosis after total hip and knee arthroplasty].
Guan Z; Chen Y; Song Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jun; 20(6):611-5. PubMed ID: 16827383
[TBL] [Abstract][Full Text] [Related]
20. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]